《盈喜》海普瑞(09989.HK)料上年度扭亏 盈利介乎5.89亿至7.11亿人币

阿斯达克财经
24 Jan

海普瑞(09989.HK) 发盈喜,预料截至2024年12月31日止年度将扭亏为盈,归属于上市公司股东的净利润将介乎5.89亿至7.11亿元人民币(下同),对比2023年度为亏损7.83亿元。基本每股收益预测达到0.4014至0.4846元,而2023年基本每股亏损为0.5338元。

过往派息
公布日期派息事项派息内容
2024/10/30第三季业绩无派息
2024/08/30中期业绩无派息
2024/04/29第一季业绩无派息
2024/03/28末期业绩无派息

公司将预料扭亏为盈归因于肝素制剂产品依诺肝素钠制剂销量保持增长、API业务整体表现按年改善、CDMO业务收入及盈利能力提升,以及对外投资组合表现理想等所带动。(gc/da)(港股报价延迟最少十五分钟。)
AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10